Friess Associates’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-33,386
Closed -$1.83M 143
2020
Q2
$1.83M Sell
33,386
-9,395
-22% -$537K 0.17% 84
2020
Q1
$2.24M Buy
+42,781
New +$2.32M 0.22% 79
2019
Q2
Sell
-37,233
Closed -$2.1M 145
2019
Q1
$2.1M Sell
37,233
-106,415
-74% -$6.34M 0.15% 93
2018
Q4
$9.16M Buy
+143,648
New +$10.2M 0.78% 56
2018
Q2
Sell
-48,966
Closed -$1.9M 145
2018
Q1
$1.9M Sell
48,966
-246,102
-83% -$8.62M 0.16% 97
2017
Q4
$8.28M Buy
295,068
+265,102
+885% +$7.77M 0.69% 64
2017
Q3
$801K Buy
+29,966
New +$572K 0.07% 95

Other funds holding TRHC

Friess Associates's TRHC Position: Q3 2020 in Review

Friess Associates sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q3 2020, closing a stake of 33,386 shares — an estimated $1.83M sold.

Friess Associates first reported a position in TRHC in Q3 2017 and held it in 7 quarters. The position peaked at $9.16M in Q4 2018. 160 funds tracked by Wall St. Rank hold TRHC as of Q3 2020.

  • Friess Associates reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Friess Associates sold 33,386 Tabula Rasa HealthCare, Inc. Common Stock shares in Q3 2020, an estimated $1.83M.
  • Friess Associates first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q3 2017 and held it in 7 quarters.
  • Friess Associates's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $9.16M in Q4 2018.
  • 160 funds tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q3 2020.

Based on Friess Associates's 13F filing for Q3 2020, filed 13 Nov 2020.